Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 1 , Pages 79-90 , March 2005

PDT with TOOKAD® studied in the chorioallantoic membrane of fertilized eggs

References 

  1. Koudinova NV, Pinthus JH, Brandis A, et al. Photodynamic therapy with Pd-bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int J Cancer. 2003;104(6):782–789
  2. Chen Q, Huang Z, Luck D, et al. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer. Photochem Photobiol. 2002;76(4):438–445
  3. Teuchner K, Stiel H, Leupold D, et al. Fluorescence and excited state absorption in modified pigments of bacterial photosynthesis: a comparative study of metal-substituted bacteriochlorophylls a. J Luminesc. 1997;72–74:612–614
  4. Bourre L, Thilbaut S, Briffaud A, et al. Indirect detection of photosensitizers ex vivo. J Photochem Photobiol B: Biol. 2002;67(1):23–31
  5. Campochiario PA, Soloway P, Ryan SJ, Miller JW. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Molec Vision. 1999;5:34–38
  6. Schmidt-Erfurth U, Miller J, Sickenberg M, et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefe's Arch Clin Exp Ophthalmol. 1998;236:365–374
  7. Rechtman E, Ciulla TA, Criswell MH, Pollack A, Harris A. An update on photodynamic therapy in age-related macular degeneration. Expert Opin Pharmacother. 2002;3(7):931–938
  8. Hunt DW, Margaron P. Status of therapies in development for the treatment of age-related macular degeneration. Idrugs. 2003;6(5):464–469
  9. Schmidt-Erfurth UM, Elsner H, Terai N, Benecke A, Dahmen G, Michels SM. Effects of verteporfin therapy on central visual filed function. Ophthalmology. 2004;111(9):931–939
  10. Brown SB, Mellish KJ. Verteporfin: a milestone in ophthalmology and photodynamic therapy. Expert Opin Pharmacother. 2001;2(2):351–361
  11. Lim J. Photodynamic therapy for choroidal neovascular diseases: photosensitizers and clinical trials. Ophthalmol Clin North Am. 2002;15:473–478
  12. Woodburn KW, Engelman CJ, Blumenkranz MS. Photodynamic therapy for choroidal neovascularization: a review. Retina. 2002;22:391–405
  13. Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T. PDT to monkey CNV with ATX-S10(Na): inappropriatness of early laser irradiation for selective occlusion. Invest Opthalmol Vis Sci. 2001;42:2639–2645
  14. Messmer KJ, Abel SR. Verteporfin for age-related macular degeneration. Ann Pharmacother. 2001;35:1593–1598
  15. Flower R, Snyder W. Expanded hypothesis on the mechanisms of photodynamic therapy action on choroidal neovascularization. Retina. 1999;19:365–369
  16. Ciardella AP, Donsoff IM, Guyer DR, Adamis A, Yannuzzi LA. Antiangiogenesis agents. Opthalmol Clin North Am. 2002;15(4):453–458
  17. Schmidt-Erfurth U, Michels S. Changes in confocal indocyanine green angiography through years after photodynamic therapy with verteporfin. Opthalmology. 2003;110(7):1306–1314
  18. Kusserow C, Michels S, Schmidt-Erfurth U. Chorioretinal anastomosis as unfarourable prognostic factor during photodynamic therapy. Ophthalmologe. 2003;100(3):197–202
  19. Schlatter P, Konig MF, Karlsson LM, Burri PH. Quantitative study of intussusceptive capillary growth in the chorioallantoic membrane (CAM) of the chicken embryo. Microvasc Res. 1997;54(1):65–73
  20. Nguyen M, Shing Y, Folkman J. Quantitation of angiogenesis and antiangiogenesis in the chick chorioallantoic membrane. Microvasc Res. 1994;47:31–40
  21. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec. 2001;264(4):317–324
  22. Kunzi-Rapp K, Rück A, Kaufmann R. Characterization of the chick chorioallantoic membrane model as a short-term in vivo system for human skin. Arch Dermatol Res. 1999;291:290–295
  23. Malik E, Meyerhöfer-Malik A, Berg Ch, et al. Fluorescence diagnosis of endometriosis on the chorioallantoic membrane using 5-amonilaevulinic acid. Hum Reprod. 2000;15(3):584–588
  24. Strauss WS, Sailer R, Schneckenburger H, et al. Photodynamic efficacy of naturally occurring porphyrins in endothelial cells in vitro and microvasculature in vivo. J Photochem Photobiol B: Biol. 1997;39(2):176–184
  25. Hammer-Wilson MJ, Akian L, Espinoza J, Kimel S, Berns MW. Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers. J Photochem Photobiol B: Biol. 1999;53(13):44–52
  26. Hornung R, Hammer-Wilson MJ, Kimel S, Liaw LH, Tadir Y, Berns MW. Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors. J Photochem Photobiol B: Biol. 1999;49(1):41–49
  27. Samkoe KS, Cramb DT. Application of an ex ovo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration. J Biomed Opt. 2003;8(3):410–417
  28. Lange N, Ballini JP, Wagnieres G, van den Bergh H. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Invest Ophthalmol Vis Sci. 2001;42(1):38–46
  29. Rück A, Köllner T, Dietrich A, Strauss W, Schneckenburger H. Fluorescence formation during photodynamic therapy in the nucleus of cells incubated with cationic and anionic water-soluble photosensitizers. J Photochem Photobiol B: Biol. 1992;12:403–412
  30. Kress M, Meier Th, Steiner R, Dolp F, Ortmann U, Rück A. Time-resolved microspectrofluorometry and fluorescence lifetime imaging of photosensitizers using picosecond pulsed diode lasers in laser scanning microscopes. J Biomed Opt. 2003;8(1):26–32
  31. Pandey RK, Constantine S, Tsuchida T, et al. Synthesis, photophysical properties, in vivo photosensitizing efficacy, and human serum albumin binding properties of some novel bacteriochlorins. J Med Chem. 1997;40:2770–2779
  32. Gottfried V, Lindenbaum ES, Kimel S. Vascular damage during PDT as monitored in the chick chorioallantoic membrane. Int J Radiat Biol. 1991;60:349–354
  33. Ribatti D, Gualandris A, Bastaki M, et al. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatine sponge/CAM assay. J Vas Res. 1997;34:455–463
  34. Gross S, Gilead A, Scherz A, Neeman M, Salomon Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med. 2003;9:1327–1331
  35. Borle F, Radu A, Monnier P, van den Bergh H, Wagnières G. Evaluation of the photosensitizer TOOKAD® for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug-light interval effects. Photochem Photobiol. 2003;78(4):377–383
  36. Tremblay A, Leroy S, Freitag L, Copin MC, Brun PH, Marquette CH. Endobronchial phototoxicity of WST09 (TOOKAD), a new fast acting photosensitizer for photodynamic therapy. Preclinical study in the pig. Photochem Photobiol. 2003;78(2):124–130
  37. Kelleher DK, Thews O, Scherz A, Salomon Y, Vaupel P. Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide. Int J Oncol. 2004;24:1505–1511
  38. Borle F, Radu A, Fontolliet C, van den Bergh H, Monnier P, Wagnieres G. Selectivity of the photosensitizer TOOKAD® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model. Br J Cancer. 2003;89:2320–2326

PII: S1572-1000(05)00006-2

doi: 10.1016/S1572-1000(05)00006-2

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 1 , Pages 79-90 , March 2005

Article Tools

* Image Usage & Resolution